Novira Therapeutics Announces Acquisition Agreement with Johnson & Johnson
See more here


First Ever Life Sciences Ecosystem Interactive Map Launched in Pennsylvania

See more here


MD Revolution and WellTrackONE Partner to Prepare Renaissance Health Network for Value Based Care
Read more here


BioAdvance Portfolio Companies Attract $85 Million of Capital in 12 Months
Read more here

 


Melior Discovery Receives Patent Approval from U.S. Patent and Trademark Office for New Parkinson’s Disease Drug Candidate
Read more here


Relmada Therapeutics Receives Health Canada Clearance to Commence First Clinical Study for Novel Oral Formulations of Buprenorphine
Read more here


Melior Pharmaceuticals Initiates Phase 2 Study with MLR-1023 for Type 2 Diabetes
Read more here


Merganser Biotech Inc. Raises $28 Million in a Series A Financing to Develop Hepcidin Mimetic Peptides
Read more here